Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
Albain, Kathy S, Prof, Barlow, William E, Prof, Ravdin, Peter M, Prof, Farrar, William B, Prof, Burton, Gary V, Prof, Ketchel, Steven J, MD, Cobau, Charles D, MD, Levine, Ellis G, MD, Ingle, James N, Prof, Pritchard, Kathleen I, Prof, Lichter, Allen S, Prof, Schneider, Daniel J, MD, Abeloff, Martin D, Prof, Henderson, I Craig, Prof, Muss, Hyman B, Prof, Green, Stephanie J, Prof, Lew, Danika, MA, Livingston, Robert B, Prof, Martino, Silvana, DO, Osborne, C Kent, Prof
Published in The Lancet (British edition) (19.12.2009)
Published in The Lancet (British edition) (19.12.2009)
Get full text
Journal Article